|Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls|
Wellcome Trust Case Control Consortium
Nature 447 (7145), 661, 2007
|Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus|
M Petri, AM Orbai, GS Alarcon, C Gordon, JT Merrill, PR Fortin, IN Bruce, ...
Arthritis & Rheumatism 64 (8), 2677-2686, 2012
|Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants|
PR Burton, DG Clayton, LR Cardon, N Craddock, P Deloukas, ...
Nature genetics 39 (11), 1329, 2007
|Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls|
N Craddock, ME Hurles, N Cardin, RD Pearson, V Plagnol, S Robson, ...
Nature 464 (7289), 713, 2010
|A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci|
Y Liu, C Helms, W Liao, LC Zaba, S Duan, J Gardner, C Wise, A Miner, ...
PLoS genetics 4 (4), e1000041, 2008
|Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A|
S Nejentsev, JMM Howson, NM Walker, J Szeszko, SF Field, HE Stevens, ...
Nature 450 (7171), 887, 2007
|EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for …|
GK Bertsias, JPA Ioannidis, M Aringer, E Bollen, S Bombardieri, IN Bruce, ...
Annals of the rheumatic diseases 69 (12), 2074-2082, 2010
|Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study|
IN Bruce, MB Urowitz, DD Gladman, D Ibañez, G Steiner
Arthritis & Rheumatism 48 (11), 3159-3167, 2003
|Rheumatoid arthritis association at 6q23|
W Thomson, A Barton, X Ke, S Eyre, A Hinks, J Bowes, R Donn, ...
Nature genetics 39 (12), 1431, 2007
|BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus …|
DA Isenberg, A Rahman, E Allen, V Farewell, M Akil, IN Bruce, D D'Cruz, ...
Rheumatology 44 (7), 902-906, 2005
|Treat-to-target in systemic lupus erythematosus: recommendations from an international task force|
RF Van Vollenhoven, M Mosca, G Bertsias, D Isenberg, A Kuhn, ...
Annals of the rheumatic diseases 73 (6), 958-967, 2014
|Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: Further support that PTPN22 is an …|
A Hinks, A Barton, S John, I Bruce, C Hawkins, CEM Griffiths, R Donn, ...
Arthritis & Rheumatism 52 (6), 1694-1699, 2005
|Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis|
U Hüffmeier, S Uebe, AB Ekici, J Bowes, E Giardina, E Korendowych, ...
Nature genetics 42 (11), 996, 2010
|Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women|
M El-Magadmi, H Bodill, Y Ahmad, PN Durrington, M Mackness, M Walker, ...
Circulation 110 (4), 399-404, 2004
|‘Not only… but also’: factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus|
Rheumatology 44 (12), 1492-1502, 2005
|Etanercept and efalizumab for the treatment of psoriasis: a systematic review.|
N Woolacott, N Hawkins, A Mason
Health technology assessment (Winchester, England) 10, 1-233, 2006
|Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study|
JG Hanly, MB Urowitz, J Sanchez‐Guerrero, SC Bae, C Gordon, ...
Arthritis & Rheumatism 56 (1), 265-273, 2007
|The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs.|
P Rahman, DD Gladman, MB Urowitz, K Yuen, D Hallett, IN Bruce
The Journal of rheumatology 26 (2), 325-330, 1999
|Premature atherosclerosis in systemic lupus erythematosus|
IN Bruce, DD Gladman, MB Urowitz
Rheumatic Disease Clinics of North America 26 (2), 257-278, 2000
|Prevention of cardiovascular disease in systemic lupus erythematosus—proposed guidelines for risk factor management|
J Wajed, Y Ahmad, PN Durrington, IN Bruce
Rheumatology 43 (1), 7-12, 2003